Personally, I think this announcement could be considered price sensitive considering all the nuances in it. This is the result of a lot of hard work in the back ground and suggestive of a well considered plan coming together. Their ready to rock and roll
The change of emphasis to Neurological diseases and not just ALS/MND is noteworthy as well.
Ann: PharmAust makes Head of Manufacturing appointment, page-2
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 21.0¢ | $85.46K | 406.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 54761 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 137129 | 2 |
View Market Depth
| Last trade - 11.50am 19/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |